Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/18817 |
Resumo: | Introduction: The ABO blood group is an example of evolutionary adaptation where, for thousands of years, microorganisms and humans interact in a symbiotic or pathological way, influencing the genetics of the populations and the evolution of the human genome by the natural selection of specific alleles capable of modifying pathogens. Objective: to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh together with various parameters in patients accompanied as a diagnosis of COVID-19. Methodology: This is a descriptive research of an integrative literature review type, which seeks to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh, together with various parameters in patients accompanied by a diagnosis of COVID-19. A research was carried out through online access to databases National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) and EBSCO Information Services, no more than July 2021. Results: The most frequently observed blood type was or A + among patients with COVID-19. The Rh + blood group was found in all cases admitted to UTI with a fatal evolution. Or blood group A was associated with an increased risk of infection, or group O was associated with a reduced risk. Conclusion: There is no way to affirm the association of blood group A positive with COVID-19 with scientifically proven results in different populations. However, the association between blood groups and other past infections cannot be ignored. |
id |
UNIFEI_8c9c988b9de572e187b504cface7e251 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/18817 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Relationship between COVID-19 and ABO blood system: clear and sufficient evidence?Relación entre COVID-19 y el sistema sanguíneo ABO: ¿evidencia clara y suficiente?Relação entre COVID-19 e sistema sanguíneo ABO: evidências claras e suficientes?Sistema ABOCOVID-19Antígeno.ABO systemCOVID-19Antigen.Sistema ABOCOVID-19Antígeno. Introduction: The ABO blood group is an example of evolutionary adaptation where, for thousands of years, microorganisms and humans interact in a symbiotic or pathological way, influencing the genetics of the populations and the evolution of the human genome by the natural selection of specific alleles capable of modifying pathogens. Objective: to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh together with various parameters in patients accompanied as a diagnosis of COVID-19. Methodology: This is a descriptive research of an integrative literature review type, which seeks to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh, together with various parameters in patients accompanied by a diagnosis of COVID-19. A research was carried out through online access to databases National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) and EBSCO Information Services, no more than July 2021. Results: The most frequently observed blood type was or A + among patients with COVID-19. The Rh + blood group was found in all cases admitted to UTI with a fatal evolution. Or blood group A was associated with an increased risk of infection, or group O was associated with a reduced risk. Conclusion: There is no way to affirm the association of blood group A positive with COVID-19 with scientifically proven results in different populations. However, the association between blood groups and other past infections cannot be ignored.Introducción: El grupo sanguíneo ABO es un ejemplo de adaptación evolutiva donde, durante miles de años, microorganismos y humanos interactuaron de forma simbiótica o patológica, influyendo en la genética de poblaciones y la evolución del genoma humano a través de la selección natural de alelos específicos capaces de modificar patogenia. Objetivo: analizar el significado pronóstico de los antígenos de los grupos sanguíneos ABO y Rh junto con diversos parámetros en pacientes seguidos con el diagnóstico de COVID-19. Metodología: Se trata de una revisión descriptiva integradora de la literatura, que buscó analizar la significación pronóstica de los antígenos de los grupos sanguíneos ABO y Rh, junto con diversos parámetros en pacientes seguidos con el diagnóstico de COVID-19. La búsqueda se realizó a través del acceso online en la Biblioteca Nacional de Medicina (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) y bases de datos EBSCO Information Services, Julio de 2021. Resultados: El tipo de sangre observado con mayor frecuencia fue A + entre los pacientes con COVID-19. El grupo sanguíneo Rh + se encontró en todos los casos ingresados en UCI y con evolución fatal. El grupo sanguíneo A se asoció con un mayor riesgo de infección, mientras que el grupo O se asoció con un riesgo reducido. Conclusión: No hay forma de afirmar la asociación del grupo sanguíneo A positivo con COVID-19 sin resultados científicamente probados en diferentes poblaciones. Sin embargo, no se puede ignorar la asociación entre grupos sanguíneos y otras infecciones en el pasado.Introdução: O grupo sanguíneo ABO é exemplo de adaptação evolutiva onde, por milhares de anos, microrganismos e humanos interagiram de forma simbiótica ou patológica, influenciando na genética das populações e na evolução do genoma humano pela seleção natural de alelos específicos capazes de modificar a patogênese. Objetivo: é analisar o significado prognóstico dos antígenos dos grupos sanguíneos ABO e Rh juntamente com vários parâmetros em pacientes acompanhados com o diagnóstico de COVID-19. Metodologia: Trata-se de uma pesquisa descritiva do tipo revisão integrativa da literatura, que buscou analisar o significado prognóstico dos antígenos dos grupos sanguíneos ABO e Rh, juntamente com vários parâmetros em pacientes acompanhados com o diagnóstico de COVID-19. A pesquisa foi realizada através do acesso online nas bases de dados National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) e EBSCO Information Services, no mês de julho de 2021. Resultados: O tipo sanguíneo mais frequentemente observado foi o A + entre os pacientes com COVID-19. O grupo sanguíneo Rh + foi encontrado em todos os casos admitidos na UTI e com evolução mortal. O grupo sanguíneo A estava associado a um risco aumentado de infecção, enquanto o grupo O estava associado com um risco reduzido. Conclusão: Não há como afirmar a associação do grupo sanguíneo A positivo com COVID-19 sem resultados cientificamente comprovados em diferentes populações. No entanto, a associação entre grupos sanguíneos e outras infecções no passado não pode ser ignorada.Research, Society and Development2021-08-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1881710.33448/rsd-v10i10.18817Research, Society and Development; Vol. 10 No. 10; e188101018817Research, Society and Development; Vol. 10 Núm. 10; e188101018817Research, Society and Development; v. 10 n. 10; e1881010188172525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/18817/17200Copyright (c) 2021 Bárbara Oliveira Vasconcelos Souto; Bárbara Queiroz de Figueiredo; Andressa Caetano Martins Silva; Bruno Faria Coury; Gabriele Durante; Gardênia Silva Amorim; Gilvane Pereira da Silva; Gustavo Alves Medeiros; Luana Damaceno Miranda; Nicolly Skarlet Souto Oliveira; Rúbia Carla Oliveirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSouto, Bárbara Oliveira VasconcelosFigueiredo, Bárbara Queiroz deSilva, Andressa Caetano MartinsCoury, Bruno FariaDurante, Gabriele Amorim, Gardênia SilvaSilva, Gilvane Pereira da Medeiros, Gustavo AlvesMiranda, Luana DamacenoOliveira, Nicolly Skarlet SoutoOliveira, Rúbia Carla2021-10-02T21:49:16Zoai:ojs.pkp.sfu.ca:article/18817Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:38:51.701428Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Relationship between COVID-19 and ABO blood system: clear and sufficient evidence? Relación entre COVID-19 y el sistema sanguíneo ABO: ¿evidencia clara y suficiente? Relação entre COVID-19 e sistema sanguíneo ABO: evidências claras e suficientes? |
title |
Relationship between COVID-19 and ABO blood system: clear and sufficient evidence? |
spellingShingle |
Relationship between COVID-19 and ABO blood system: clear and sufficient evidence? Souto, Bárbara Oliveira Vasconcelos Sistema ABO COVID-19 Antígeno. ABO system COVID-19 Antigen. Sistema ABO COVID-19 Antígeno. |
title_short |
Relationship between COVID-19 and ABO blood system: clear and sufficient evidence? |
title_full |
Relationship between COVID-19 and ABO blood system: clear and sufficient evidence? |
title_fullStr |
Relationship between COVID-19 and ABO blood system: clear and sufficient evidence? |
title_full_unstemmed |
Relationship between COVID-19 and ABO blood system: clear and sufficient evidence? |
title_sort |
Relationship between COVID-19 and ABO blood system: clear and sufficient evidence? |
author |
Souto, Bárbara Oliveira Vasconcelos |
author_facet |
Souto, Bárbara Oliveira Vasconcelos Figueiredo, Bárbara Queiroz de Silva, Andressa Caetano Martins Coury, Bruno Faria Durante, Gabriele Amorim, Gardênia Silva Silva, Gilvane Pereira da Medeiros, Gustavo Alves Miranda, Luana Damaceno Oliveira, Nicolly Skarlet Souto Oliveira, Rúbia Carla |
author_role |
author |
author2 |
Figueiredo, Bárbara Queiroz de Silva, Andressa Caetano Martins Coury, Bruno Faria Durante, Gabriele Amorim, Gardênia Silva Silva, Gilvane Pereira da Medeiros, Gustavo Alves Miranda, Luana Damaceno Oliveira, Nicolly Skarlet Souto Oliveira, Rúbia Carla |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Souto, Bárbara Oliveira Vasconcelos Figueiredo, Bárbara Queiroz de Silva, Andressa Caetano Martins Coury, Bruno Faria Durante, Gabriele Amorim, Gardênia Silva Silva, Gilvane Pereira da Medeiros, Gustavo Alves Miranda, Luana Damaceno Oliveira, Nicolly Skarlet Souto Oliveira, Rúbia Carla |
dc.subject.por.fl_str_mv |
Sistema ABO COVID-19 Antígeno. ABO system COVID-19 Antigen. Sistema ABO COVID-19 Antígeno. |
topic |
Sistema ABO COVID-19 Antígeno. ABO system COVID-19 Antigen. Sistema ABO COVID-19 Antígeno. |
description |
Introduction: The ABO blood group is an example of evolutionary adaptation where, for thousands of years, microorganisms and humans interact in a symbiotic or pathological way, influencing the genetics of the populations and the evolution of the human genome by the natural selection of specific alleles capable of modifying pathogens. Objective: to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh together with various parameters in patients accompanied as a diagnosis of COVID-19. Methodology: This is a descriptive research of an integrative literature review type, which seeks to analyze or prognostic meaning of two antigens of two blood groups ABO and Rh, together with various parameters in patients accompanied by a diagnosis of COVID-19. A research was carried out through online access to databases National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) and EBSCO Information Services, no more than July 2021. Results: The most frequently observed blood type was or A + among patients with COVID-19. The Rh + blood group was found in all cases admitted to UTI with a fatal evolution. Or blood group A was associated with an increased risk of infection, or group O was associated with a reduced risk. Conclusion: There is no way to affirm the association of blood group A positive with COVID-19 with scientifically proven results in different populations. However, the association between blood groups and other past infections cannot be ignored. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-08-08 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/18817 10.33448/rsd-v10i10.18817 |
url |
https://rsdjournal.org/index.php/rsd/article/view/18817 |
identifier_str_mv |
10.33448/rsd-v10i10.18817 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/18817/17200 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 10; e188101018817 Research, Society and Development; Vol. 10 Núm. 10; e188101018817 Research, Society and Development; v. 10 n. 10; e188101018817 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052685943308288 |